NCT06026865View on ClinicalTrials.gov

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

June 1, 2026

Conditions
Primary Sclerosing Cholangitis (PSC)
Interventions
DIETARY_SUPPLEMENT

S-Adenosyl-L-methionine (SAMe)

S-adenosyl-L-methionine 1200 mg/daily as 2400mg S-Adenosyl-L-methionine disulfate tosylate

OTHER

Placebo

Placebo of identical appearance, smell and taste, with the same schedule.

Trial Locations (1)

Unknown

Department of Hepatology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw

All Listed Sponsors
collaborator

National Science Centre, Poland

OTHER_GOV

lead

Medical University of Warsaw

OTHER